- Accueil >
- Publications >
- Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial
Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial
Auteurs
Gianni Bisogno, Meriel Jenney, Christophe Bergeron, Soledad Gallego Melcón, Andrea Ferrari, Odile Oberlin, Modesto Carli, Michael Stevens, Anna Kelsey, Angela De Paoli, Mark N Gaze, Helene Martelli, Christine Devalck, Johannes H Merks, Myriam Ben-Arush, Heidi Glosli, Julia Chisholm, Daniel Orbach, Veronique Minard-Colin, Gian Luca De Salvo, Maja Cesen, Adriana Rose, Sima Ferman, Peter Mudry, Daniela Sejnova, Paola Dal Bianco, Ilaria Zanetti, Felix Niggli, Timothy Rogers, Giovanni Cecchetto, Federica De Corti, Florent Guerin, Sheila Terwisscha, Dominique Ranchere, Rita Alaggio, Janet Shipley, Angelo Rosolen, Henry Mandeville, Giovanni Scarzello, Valerie Bernier, Kieran McHugh